Introduction

In the Department of Nuclear Medicine, radiopharmaceuticals are used to evaluate organ function, diagnose and treat diseases. Nuclear medicine imaging tests are useful for diagnosing diseases early or finding hidden diseases by using radiopharmaceuticals to check the physiological changes that appear in the early stages of disease.

Major fields include nuclear medicine imaging diagnosis, radiopharmaceutical treatment (thyroid cancer, hyperthyroidism, neuroendocrine tumor), and diagnosis and treatment of osteoporosis.

In particular, the Department of Nuclear Medicine uses a gamma camera to check and diagnose functions and damage of body organs such as brain and nervous system diseases, heart diseases, bone diseases, and kidney diseases, and to perform positron emission tomography (PET/CT), a state-of-the-art medical device. It is playing an important role in the early diagnosis of various cancers, the staging of diseases, and the determination of treatment directions.
Recently, various radiopharmaceuticals are used to diagnose bone metastases in patients with brain nervous system diseases such as Parkinson's disease and Alzheimer's disease, neuroendocrine tumors, and cancer, as well as bone density tests for osteoporosis and sarcopenia.
In addition, in the Department of Nuclearb Medicine, professional medical staff provide radioactive iodine treatment for patients with thyroid cancer and hyperthyroidism, and radiopharmaceutical treatment for patients with neuroendocrine tumors.

In the Department of Nuclear Medicine at Kyung Hee University Medical Center, professional medical staff are working hard to provide safe and useful nuclear medicine imaging diagnosis and effective radiopharmaceutical treatment.

Positron emission tomography (PET-CT)

What is PET-CT?

By administering a radiopharmaceutical combined with a radioisotope that emits positrons, it is a test to check metabolic changes in the body or to detect cancer early and to check whether it has metastasized to other organs.

When PET-CT is required

Early detection of cancer, staging, prediction and evaluation of treatment effects

- Early diagnosis of various cancers

- Differentiation of benign and malignant tumors and evaluation of cancer malignancy

- Diagnosis of distribution and staging of cancer

- Early diagnosis of cancer recurrence

- Evaluation of treatment effect

- Determination of the location of the biopsy

- Radiation therapy range setting nervous system disease

movement disorders such as Parkinson’s disease

- Diagnosis of dementia and identification of cause diseases heart disease

- Diagnosis of dementia and identification of cause diseases

heart disease

- survival myocardial evaluation

- diagnosis of coronary artery dissease

Bone scan

- This test evaluates fractures or cancer metastasis, infection, and joint disease by administering radiopharmaceuticals that reflect bone metabolism.

myocardial perfusion tomography

- It is a test that can accurately evaluate the severity of coronary artery disease by observing the blood supply to the heart muscle in a three-dimensional image. Diagnosis is made by comparing the loading image and the resting image, which put stress on the heart with drugs.

Other imaging tests

- Cerebral perfusion SPECT, salivary gland scan, thyroid scan, kidney scan, hepatobiliary tract scan, lung scan, bone density scan

radioactive iodine treatment

- Radioactive iodine selectively absorbed by the thyroid gland is used to remove residual tissue after surgery for thyroid cancer or to treat metastatic thyroid cancer. Even if a patient with hyperthyroidism does not respond to antithyroid drugs or it recurs, radioiodine can be used for treatment.

Medical Fields

Features